PRINCETON, N.J., Oct. 3, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Chief Scientific Officer, Oreola Donini, PhD, will deliver a corporate presentation to revie

CRANFORD, N.J., Oct. 3, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported Company activities at ID Week, the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology

BOSTON, Oct. 3, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its mach

LOS ANGELES, Oct. 3, 2019 /PRNewswire/ -- Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced the closing of its fully-subscribed series B financing. The capital raised will fund a large-scale, pre-launch, phase 4 trial for AtopX™ Eczema Emulsion, with enrollment schedule

MONTREAL and CHARLOTTE, N.C., Oct. 3, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced that the first patient has been enrolled in the Phase

INDIANAPOLIS, Oct. 3, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented detailed data at the 5th Annual Maui Derm NP+PA Fall meeting from the Phase 4 IXORA-R study, the first head-to-head (H2H) study between an IL-17A inhibitor and an IL-23/p19 inhibitor using the Psoriasis Area Severity Index (PASI) 100 score as the primary endp

NASHVILLE, Tenn., Oct. 3, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today mailed a letter to stockholders in connection with its 2019 Annual Meeting of Stockholders (the "2019 Annual Meeting"). Brookdale stockholders of record as of the close of business on September 9, 2019 will be entitled

LONDON, Oct. 3, 2019 /PRNewswire/ -- Focused on improving surgical performance and outcomes, Digital Surgery is proud to announce centre accreditation by the Royal College of Surgeons England to award CPD points for cognitive rehearsal and case reflection using Digital Surgery's Touch Surgery mobile and web platform. This marks the first time

MINNEAPOLIS, Oct. 3, 2019 /PRNewswire/ -- ExceleraRx Corp® announced today that members of the Excelera Network will have access to VYNDAQEL® (tafamidis meglumine) and

TORONTO, Oct. 3, 2019 /PRNewswire/ -- AmacaThera Inc. (www.amacathera.ca) is pleased to announce the closing of its US $3.6M seed financing round. A firs